Fig. 6
From: Investigating the PI3K/AKT/mTOR axis in Buzhong Yiqi Decoction’s anti-colorectal cancer activity
BZYQD inhibits crc cell proliferation and migration via PI3K/Akt/mTOR axis inhibition. (A, B) The impact of BZYQD, LY294002, and IGF-1 on CRC cell proliferation (DNA stained blue and proliferating cells marked in green). (C, D) The influence of BZYQD, LY294002, and IGF-1 on CRC cell migration. Data are expressed as mean ± SEM (n = 3). **P < 0.01 vs. the Con group, ##P < 0.01 vs. the BZYQD group.
